Literature DB >> 31129809

Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference.

Gofarana Wilar1,2, Yasuharu Shinoda1, Toshikuni Sasaoka3, Kohji Fukunaga4.   

Abstract

Nicotine in tobacco causes psychological dependence through its rewarding effect in the central nervous system (CNS). Although nicotine dependence is explained by dopamine receptor (DR) signaling together with nicotinic acetylcholine receptors (nAChRs), the synaptic molecular mechanism underlying the interaction between dopamine receptor and nAChRs remains unclear. Since reward signaling is mediated by dopamine receptors, we hypothesized that the dopamine D2 receptor (D2R), in part, mediates the synaptic modulation of nicotine-induced conditioned place preference (CPP) in addition to dopamine D1 receptor. To investigate the involvement of D2R, wild-type (WT) and dopamine D2 receptor knockout (D2RKO) mice were assessed using the CPP task after induction of nicotine-induced CPP. As expected, D2RKO mice failed to induce CPP behaviors after repeated nicotine administration (0.5 mg/kg). When kinase signaling was assessed in the nucleus accumbens and hippocampal CA1 region after repeated nicotine administration, both Ca2+/calmodulin-dependent protein kinase (CaMKII) and extracellular signal-regulated kinase (ERK) were upregulated in WT mice but not in D2RKO mice. Likewise, nicotine-induced CPP was associated with elevation of pro- brain-derived neurotropic factor (BDNF) and BDNF protein levels in WT mice, but not in D2RKO mice. Taken together, in addition to dopamine D1 receptor signaling, dopamine D2 receptor signaling is critical for induction of nicotine-induced CPP in mice.

Entities:  

Keywords:  Brain-derived neurotrophic factor; Conditioned placed preference; Dopamine D2 receptor; Nicotine dependence

Mesh:

Substances:

Year:  2019        PMID: 31129809     DOI: 10.1007/s12035-019-1635-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  71 in total

Review 1.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

2.  Activation of muscarinic and nicotinic acetylcholine receptors in the nucleus accumbens core is necessary for the acquisition of drug reinforcement.

Authors:  Jose A Crespo; Katja Sturm; Alois Saria; Gerald Zernig
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

3.  Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice.

Authors:  Bridgin G Lee; Agustin Anastasia; Barbara L Hempstead; Francis S Lee; Julie A Blendy
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

4.  Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum.

Authors:  Mumtaz Jamal; Willem Van der Does; Bernet M Elzinga; Marc L Molendijk; Brenda W J H Penninx
Journal:  Nicotine Tob Res       Date:  2014-09-02       Impact factor: 4.244

5.  Potassium channel blocker activates extracellular signal-regulated kinases through Pyk2 and epidermal growth factor receptor in rat cardiomyocytes.

Authors:  S Tahara; K Fukuda; H Kodama; T Kato; S Miyoshi; S Ogawa
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

6.  Association of specific haplotypes of neurotrophic tyrosine kinase receptor 2 gene (NTRK2) with vulnerability to nicotine dependence in African-Americans and European-Americans.

Authors:  Joke Beuten; Jennie Z Ma; Thomas J Payne; Randolph T Dupont; Xiang-Yang Lou; Karen M Crews; Robert C Elston; Ming D Li
Journal:  Biol Psychiatry       Date:  2006-05-19       Impact factor: 13.382

7.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

8.  A new aspect of the TrkB signaling pathway in neural plasticity.

Authors:  K Ohira; M Hayashi
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

9.  Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress.

Authors:  Y Yabuki; K Fukunaga
Journal:  Neuroscience       Date:  2013-07-18       Impact factor: 3.590

10.  Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism.

Authors:  Barbara Picconi; Fabrizio Gardoni; Diego Centonze; Daniela Mauceri; M Angela Cenci; Giorgio Bernardi; Paolo Calabresi; Monica Di Luca
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

View more
  5 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Wenbin Jia; Gofarana Wilar; Ichiro Kawahata; An Cheng; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  TET1-induced DNA demethylation in dentate gyrus is important for reward conditioning and reinforcement.

Authors:  Sneha Sagarkar; Nagashree Bhat; Madhura Sapre; Biru Dudhabhate; Dadasaheb M Kokare; Nishikant K Subhedar; Amul J Sakharkar
Journal:  Mol Neurobiol       Date:  2022-06-16       Impact factor: 5.682

Review 4.  Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction.

Authors:  Angela M Lee; Marina R Picciotto
Journal:  Adv Pharmacol       Date:  2020-10-06

5.  Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice.

Authors:  Ilaria Morella; Veronika Pohořalá; Claudia Calpe-López; Riccardo Brambilla; Rainer Spanagel; Rick E Bernardi
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.